1 completed, 1 not yet recruiting, 1 recruiting. 3 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Completed 1, Not yet recruiting 1, Recruiting 1 |
| Phase 1 | 1 | Recruiting 1 |
Follow TUDCA: new trials by email Literature Review of TUDCA trials Research Report on TUDCA
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| TUDCA in High-Risk Lactating Mothers Identified by Early Postpartum Milk Hydrophobicity Index tauroursodeoxycholic acid (TUDCA), Placebo - Metabolic Dysfunction-Associated Steatotic Liver Disease Infant Development | Phase 2 | Not yet recruiting | Peking University First Hospital | 80 | 2026-04-02 | 2026-04-08 |
| Targeting Endoplasmic Reticulum Stress in Human Hypertension TUDCA, Placebo - Hypertension | Phase 1 / Phase 2 | Recruiting | University of North Texas Health Science Center | 70 | 2023-08-15 | 2025-03-28 |
| Tauroursodeoxycholic Acid (TUDCA) in New-Onset Type 1 Diabetes Tauroursodeoxycholic Acid (TUDCA), Sugar Pill (placebo) - Type 1 Diabetes | Phase 2 | Completed | Robin Goland, MD | 20 | 2015-08-01 | 2025-06-05 |
Diabetes Mellitus, Type 1 (1) · Hypertension (1) · Ichthyosis prematurity syndrome (1)
Peking University First Hospital (1) · Robin Goland, MD (1) · University of North Texas Health Science Center (1)
United States (2)
Robin Goland, MD (1) · Rudolph Leibel, MD (1) · Yuhang Zhang, MD, PhD (1)